Posts in category: Uncategorized

The Food and Drug Administration (FDA) has recalled dozens of over-the-counter lubricating eye drops and artificial tears in 2023 due to contamination and unsafe manufacturing practices.

Treatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates with poorer treatment outcomes, finds a recent study.

A team of UC Davis researchers led by bioengineer Aijun Wang has designed and tested a supportive structure, called a scaffold, that can help large deep burn wounds heal faster. The promising new treatment was found to promote the formation of new blood vessels and reduce complications linked to open burn wounds. It may also reduce the need for skin grafting in patients with significant burns over their body.

The health care systems in the Asia-Pacific region are under the threat of an aging population and the growing demands for medical services. In response to these challenges, out-of-hospital care bolstered by digital medical technologies has been identified as a feasible solution.

Socioeconomic factors, like education and location, can affect access to life-saving prenatal care services. Researchers at Boston Children’s Hospital are taking steps towards implementing strategies that improve access to prenatal care: estimating how many pregnant people attend the recommended number of visits and identifying pregnant people who are at high risk of failing to attend. This could help policymakers allocate resources to populations not getting enough prenatal care and could, in turn, improve health outcomes for mothers and babies.

Exercise intolerance, or the inability to perform physical activity at the expected or desired level, is one of the many symptoms associated with long COVID. In a study, Yale researchers help explain what is explicitly driving this symptom, offering much-needed information for patients and generating new directions for future research.

Learning health systems (LHS) is a multidisciplinary research field that seeks to improve clinical decision-making, promote personalized medicine, and identify best practices to optimize patient outcomes. By creating a feedback loop between real-time research and practitioners in the field, LHS aims to improve information access for scholars and accelerate the translation of knowledge into tangible improvements in patient care.

An exploratory clinical trial (SIGMA4COVID) through a collaboration between Catalonia and Galicia, the results of which are published in the Journal of Infection, suggests the usefulness of a drug, E-52862, for the treatment of patients with mild COVID-19 symptoms. If these findings are confirmed, it will be one of the few useful treatments in these cases, with the addition that it could be administered on an outpatient basis through primary care centers.

A new study led by SMU medical and psychological anthropologist Neely Myers indicates that while young people diagnosed with early psychosis understand the importance of discontinuing the use of substances like cannabis, many are ambivalent about stopping.

In cases of opioid use disorder, short-term medically managed withdrawal (commonly known as detox) and long-term rehabilitation treatments that don’t incorporate continued use of buprenorphine or methadone are no more effective at preventing overdose deaths than no treatment at all, a new Yale-led study reveals.